Question 1

What are the main strengths of investing in MDT?

Accepted Answer

The main strengths of investing in Medtronic plc include: Global medical technology leader with 71% patient success rates and healthcare access for 78M+, Strong ESG performance with 52% emissions reduction and carbon neutral goal by 2030, Robust innovation pipeline driving mid-single digit growth with strategic portfolio focus.

Question 2

What are the potential drawbacks of investing in MDT?

Accepted Answer

Potential drawbacks of investing in Medtronic plc include: Diabetes business separation creating transition risks and portfolio restructuring challenges, Intense competition in medical devices from both established players and new entrants, Healthcare reimbursement pressures and regulatory changes affecting device adoption.

Question 3

What are the key financial metrics for MDT?

Accepted Answer

Key financial metrics for Medtronic plc include: Market Cap: $5.70 billion, Current Price: $244.61, Dividend Yield: 3.30%.

Medtronic plc

Key Statistics

Valuation

Trading Info

52 Week

Dividends

Detailed View

MDT

ESG Ratings